The North America Liquid Biopsy Market is supported by sophisticated diagnostic infrastructure and strong investment in cancer research. The region's focus on precision medicine is encouraging the development and adoption of advanced molecular testing technologies. The Liquid Biopsy Market was estimated at US$ 4.57 billion in 2021 and is expected to reach US$ 12.69 million by 2031, registering...